Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.
about
Ruthenium polypyridyl complex inhibits growth and metastasis of breast cancer cells by suppressing FAK signaling with enhancement of TRAIL-induced apoptosis.Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity.The chicken chorioallantoic membrane model in biology, medicine and bioengineeringAnticancer Organometallic Osmium(II)-p-cymene Complexes.Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.
P2860
Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Synthesis and characterization ...... s based on ruthenium clusters.
@en
Synthesis and characterization ...... s based on ruthenium clusters.
@nl
type
label
Synthesis and characterization ...... s based on ruthenium clusters.
@en
Synthesis and characterization ...... s based on ruthenium clusters.
@nl
prefLabel
Synthesis and characterization ...... s based on ruthenium clusters.
@en
Synthesis and characterization ...... s based on ruthenium clusters.
@nl
P2093
P2860
P50
P356
P1433
P1476
Synthesis and characterization ...... s based on ruthenium clusters.
@en
P2093
Arjan W Griffioen
Danielle M Chisholm
Hubert van den Bergh
J Scott McIndoe
Judy R van Beijnum
Mathurin Baquié
Patrycja Nowak-Sliwinska
Zohrab Ahmadi
P2860
P2888
P356
10.1038/SREP01485
P407
P577
2013-01-01T00:00:00Z